CAPC

Serial Number 97564180
Registration 7211107
700

Registration Progress

Application Filed
Aug 25, 2022
Under Examination
Approved for Publication
Aug 22, 2023
Published for Opposition
Aug 22, 2023
Registered
Nov 7, 2023

Trademark Image

CAPC

Basic Information

Serial Number
97564180
Registration Number
7211107
Filing Date
August 25, 2022
Registration Date
November 7, 2023
Published for Opposition
August 22, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 7, 2023
Registration
Registered
Classes
001 005

Rights Holder

Phoreus Biotechnology, Inc.

03
Address
22201 W. Innovation Drive
Olathe, KS 66061

Ownership History

Phoreus Biotechnology, Inc.

Original Applicant
03
Olathe, KS

Phoreus Biotechnology, Inc.

Owner at Publication
03
Olathe, KS

Phoreus Biotechnology, Inc.

Original Registrant
03
Olathe, KS

Legal Representation

Attorney
Crissa A. Cook

USPTO Deadlines

Next Deadline
1396 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231107)
Due Date
November 07, 2029
Grace Period Ends
May 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Nov 7, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 7, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 22, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 22, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 17, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 13, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical, biological, and diagnostic reagents and preparations for scientific, medical and veterinary research use; Biological preparations, other than for medical use, namely, for use in biotechnological product development, manufacture of vaccines, drugs and medicines; Biochemical reagents in the form of peptide capsules, microspheres, or nanospheres used for non-medical purposes; Fertilizers for agricultural use; Fertilizers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of horticultural preparations, plant nutrients, and soil amendments
First Use Anywhere: Jul 26, 2019
First Use in Commerce: Apr 18, 2022
Class 005
Preparations and substances for facilitating delivery of active substances, namely, a drug delivery agent in the form of peptide capsules, microspheres, or nanospheres for delivering nucleic acids, proteins, enzymes, small molecules, therapeutic drugs, organic compounds, plasmids, dyes, nutrients, minerals, colloidal metal, pesticides, insecticides, parasiticides, and fungicides to cells; Peptides for drug delivery, namely, drug delivery agents consisting of peptide capsules, microspheres, or nanospheres containing or attached to active substances that facilitate delivery of a wide variety of pharmaceutical or veterinary preparations; Carriers in the form of peptide capsules, microspheres, or nanospheres used as vehicles to deliver active substances in the nature of pharmaceutical or veterinary preparations; Diagnostic agents for medical or veterinary purposes, namely, diagnostic agents in the form of peptide capsules, microspheres, or nanospheres containing or attached to imaging agents for medical or veterinary purposes; Peptide-based preparations for destroying vermin; Fungicides; Herbicides; Imaging agents in the form of peptide capsules, microspheres, or nanospheres for medical and veterinary diagnostic purposes, namely, contrasting agents for ultrasound or near-infrared diagnostic imaging, diagnostic radiopharmaceutical agent for use in PET imaging, imaging agents for magnetic resonance imaging (MRI), radiopharmaceutical imaging agents for diagnosing and monitoring cancer
First Use Anywhere: Jul 26, 2019
First Use in Commerce: Apr 18, 2022

Additional Information

Pseudo Mark
CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS

Classification

International Classes
001 005